Radiology Doctors in Mt Shasta, CA Accepting Medicare
1 Radiology doctors found. Showing 1 - 1
 Dr. Scott L. Bleazard, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 914 Pine St, Mt Shasta, CA 96067 Phone: 530-926-9329 Fax: 855-251-4626 |
News Archive
OAA, AOA form SUN alliance
The American Optometric Association (AOA) and the Opticians Association of America (OAA), with sponsorship from Luxottica and The Vision Council, have formed a SUN alliance designed to empower practices and businesses with the training and information needed to educate and prescribe appropriate sun protection for every patient.
Study: Majority of overweight or obese patients happy with abdominoplasty
Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.
British Columbia first in Canada to include Prevnar 13 in routine child immunization program
British Columbia is leading the way in vaccinations to protect children from serious disease. The province is the first in Canada to include Prevnar 13, the vaccine that provides the broadest coverage available against Streptococcus pneumoniae that may cause invasive pneumococcal disease, in the routine child immunization program.
Researchers identify 22 genetic variations associated with increased risk of prostate cancer
Prostate cancer affects one out of every 6 men during their lifetime and is the second most common cause of cancer-related death for men in the United States, resulting in an estimated 27,500 deaths in 2015. Identifying those men who have a higher risk of developing prostate cancer may reduce mortality.
FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC
The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.
› Verified 8 days ago